Clinical Trial Update: Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia

View source ↗

Summary

This clinical trial investigates using a genome-wide SNP array approach to predict chemosensitivity and survival in patients with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Samsung Medical Center | Conditions: Acute Lymphoblastic Leukemia | Status: UNKNOWN